Roche's Acetmra arthritis drug falls short in coronavirus trial
June 19 2020, 08:00
The drug showed no benefit in terms of entry into intensive care or in terms of survival, the Italian Medicines Agency said.
The drug showed no benefit in terms of entry into intensive care or in terms of survival, the Italian Medicines Agency said.
Source:
FOX News